Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-036985
Filing Date
2010-07-02
Accepted
2010-07-02 15:23:21
Documents
1
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c01409_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c01409_4x0.xml 4 26612
  Complete submission text file 0001209191-10-036985.txt   28491
Mailing Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617-349-4500
JAVELIN PHARMACEUTICALS, INC (Issuer) CIK: 0000050710 (see all company filings)

EIN.: 880471759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAVELIN PHARMACEUTICALS, INC. 125 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address
Carr Daniel B (Reporting) CIK: 0001311634 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32949 | Film No.: 10935937